Table 2

Response rates

VariablesBortezomibControlTest*
n% (n)n% (n)P value
At randomization 179  180   
 ≥nCR  20.1 (36)  20.6 (37)  
 VGPR  19.6 (35)  18.3 (33)  
 PR  51.4 (92)  50.0 (90)  
 MR  7.3 (13)  8.9 (16)  
 SD  1.7 (3)  2.2 (4)  
Best response 182  183   
 ≥nCR  45.1 (82)  35.0 (64)  
 VGPR  25.8 (47)  22.4 (41)  
 PR  25.3 (46)  38.3 (70)  
 MR  2.7 (5)  3.3 (6)  
 SD  0.5 (1)  0.5 (1)  
 PD  0.5 (1)  0.5 (1)  
 ≥nCR  45.1 (82)  35.0 (64) .055 
 ≥VGPR  70.9 (129)  57.4 (105) .0088 
VariablesBortezomibControlTest*
n% (n)n% (n)P value
At randomization 179  180   
 ≥nCR  20.1 (36)  20.6 (37)  
 VGPR  19.6 (35)  18.3 (33)  
 PR  51.4 (92)  50.0 (90)  
 MR  7.3 (13)  8.9 (16)  
 SD  1.7 (3)  2.2 (4)  
Best response 182  183   
 ≥nCR  45.1 (82)  35.0 (64)  
 VGPR  25.8 (47)  22.4 (41)  
 PR  25.3 (46)  38.3 (70)  
 MR  2.7 (5)  3.3 (6)  
 SD  0.5 (1)  0.5 (1)  
 PD  0.5 (1)  0.5 (1)  
 ≥nCR  45.1 (82)  35.0 (64) .055 
 ≥VGPR  70.9 (129)  57.4 (105) .0088 

MR, minor response; SD, stabile disease; PD, progressive disease.

*

Fisher’s exact test, exact significance (2-sided).

Eleven patients had unconfirmed responses at the time of randomization.

Five patients had incomplete follow-up.

Close Modal

or Create an Account

Close Modal
Close Modal